130 related articles for article (PubMed ID: 5431049)
1. Folate deficiency in the myeloproliferative disorders.
Chanarin I
Am J Clin Nutr; 1970 Jun; 23(6):855-60. PubMed ID: 5431049
[No Abstract] [Full Text] [Related]
2. High prevalence of hyperhomocysteinemia due to marginal deficiency of cobalamin or folate in chronic myeloproliferative disorders.
Faurschou M; Nielsen OJ; Jensen MK; Hasselbalch HC
Am J Hematol; 2000 Oct; 65(2):136-40. PubMed ID: 10996831
[TBL] [Abstract][Full Text] [Related]
3. [Metamorphosis of chronic myeloproliferative diseases].
Butoianu E; Nicoară S; Coliţă A; Ursea C; Berceanu S
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(3):223-32. PubMed ID: 6140716
[No Abstract] [Full Text] [Related]
4. Secondary gout associated with chronic myeloproliferative disorders.
Yu T; Weinreb N; Wittman R; Wasserman LR
Semin Arthritis Rheum; 1976 Feb; 5(3):247-56. PubMed ID: 1062009
[No Abstract] [Full Text] [Related]
5. Chorea with transitional myeloproliferative disease.
Coppack SW; Gibberd FB
J R Soc Med; 1985 Oct; 78(10):864-6. PubMed ID: 4045892
[No Abstract] [Full Text] [Related]
6. Myeloproliferative neoplasms cause glomerulopathy.
Said SM; Leung N; Sethi S; Cornell LD; Fidler ME; Grande JP; Herrmann S; Tefferi A; D'Agati VD; Nasr SH
Kidney Int; 2011 Oct; 80(7):753-9. PubMed ID: 21654720
[TBL] [Abstract][Full Text] [Related]
7. When to use chemotherapy for chronic hematopoietic neoplasms.
Yu KP; Krakoff IH
Postgrad Med; 1968 May; 43(5):176-83. PubMed ID: 5239464
[No Abstract] [Full Text] [Related]
8. THE SERUM LACTOBACILLUS CASEI FOLATE CLEARANCE TEST IN VARIOUS HEMATOLOGIC DISORDERS.
HOGAN JA; MANIATIS A; MOLONEY WC
Blood; 1964 Aug; 24():187-97. PubMed ID: 14200254
[No Abstract] [Full Text] [Related]
9. [Pathogenesis and manifestation of disturbances of erythropoiesis and granulopoiesis in myeloproliferative syndromes].
Meuret G; Hoffmann G
Klin Wochenschr; 1972 Sep; 50(18):853-61. PubMed ID: 4562533
[No Abstract] [Full Text] [Related]
10. Polycythemia vera, myeloid metaplasia with terminal myelogenous leukemia.
LITWINS J; GREENWALD L; GREENWALD HP
Bulletin NY Med Coll; 1955; 18():38-45. PubMed ID: 13329577
[No Abstract] [Full Text] [Related]
11. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
Iványi JL; Marton E; Plander M
Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
[TBL] [Abstract][Full Text] [Related]
12. Development of polycythemia vera in a patient with myeloid metaplasia and myelofibrosis. Report of a case with a comment on its significance in relation to prevailing views on myeloid metaplasia.
Hershko C; Polliack A
Isr J Med Sci; 1971 Feb; 7(2):315-20. PubMed ID: 5560987
[No Abstract] [Full Text] [Related]
13. The relationship of erythromonocytic leukemia to other myeloproliferative disorders.
Shaw MT; Bottomley SS; Bottomley RH; Hussein KK
Am J Med; 1973 Oct; 55(3):542-8. PubMed ID: 4355172
[No Abstract] [Full Text] [Related]
14. Chronic myeloproliferative diseases.
de Lacerda JF; Oliveira SN; Ferro JM
Handb Clin Neurol; 2014; 120():1073-81. PubMed ID: 24365372
[TBL] [Abstract][Full Text] [Related]
15. [Clinical conference: Histaaminemia in myeloproliferative syndromes].
Cadiou M; Ruff F; Meunier F; Attalah N; Bernadou A; Zittoun R; Parrot JL; Bousser J
Nouv Rev Fr Hematol; 1975; 15(2):261-9. PubMed ID: 126436
[No Abstract] [Full Text] [Related]
16. Risk of infection in MPN patients in the era of Covid-19: A prospective multicenter study of 257 patients from the CML-MPN Quebec Research Group.
Simpson-Poirier K; Harnois M; Olney HJ; Sirhan S; Gratton MO; Assouline S; Laneuville P; Delage R; Mollica L; Busque L; Szuber N
Am J Hematol; 2021 Jun; 96(6):E200-E203. PubMed ID: 33719144
[No Abstract] [Full Text] [Related]
17. Metabolism of human prothrombin and fibrinogen in patients with thrombocytosis secondary to myeloproliferative states.
Martinez J; Shapiro SS; Holburn RR
Blood; 1973 Jul; 42(1):35-46. PubMed ID: 4736876
[No Abstract] [Full Text] [Related]
18. Megaloblastic anemia due to folic acid deficiency in polycythemia vera.
Whittemore NB; Townsend SR; Cameron DG
Can Med Assoc J; 1967 Dec; 97(24):1487-9. PubMed ID: 6061613
[No Abstract] [Full Text] [Related]
19. Folate deficiency in polycythaemia rubra vera.
Kremenchuzky S; Hoffbrand AV
Br J Haematol; 1965 Sep; 11(5):600-8. PubMed ID: 5830028
[No Abstract] [Full Text] [Related]
20. [Novel method in diagnosis of chronic myeloproliferative disorders--detection of JAK2 mutation].
Rajnai H; Bödör C; Reiniger L; Timár B; Csernus B; Szepesi A; Csomor J; Matolcsy A
Orv Hetil; 2006 Nov; 147(45):2175-9. PubMed ID: 17402211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
